Precision BioSciences Fires New Round In DNA IP Feud

Law360, Los Angeles (September 27, 2011, 7:58 PM EDT) -- Biotechnology company Precision BioSciences Inc. slammed French rival and ongoing litigation foe Cellectis SA with an infringement suit Monday in North Carolina over a patent for meganucleases, molecular scissors used for highly targeted DNA modification.

According to the suit, Cellectis and two subsidiaries have violated U.S. Patent Number 8,021,867, issued to Duke University on Sept. 20 and for which Precision claims to have an exclusive license.

“Precision is the exclusive licensee of the ‘867 patent and owner of all substantial rights therein and thereto,” the complaint...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.